Additionally, Altera is designed to profile 440 medically important genes by whole genome sequencing (WGS) including all glioma-relevant SNPs except for p-TERT DNA sequence alterations (Comprehensive Genomic Profiling, 2023). This evidence concerns the gene TERT and glioma.